Ponesimod
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 145 publications
Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study.
Journal: Frontiers in neurology
Published: January 08, 2026
Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.
Journal: The Annals of pharmacotherapy
Published: January 03, 2026
The comparative efficacy of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis: Updated meta-regression estimates by patient subgroup.
Journal: Multiple sclerosis and related disorders
Published: December 20, 2025
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
Journal: Therapeutic advances in neurological disorders
Published: November 09, 2025
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.
Journal: Journal of neurology
Published: November 03, 2025
Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.
Journal: Frontiers in immunology
Published: October 28, 2025
Structural insights into subtype-specific agonist recognition by sphingosine-1-phosphate receptors.
Journal: PLoS biology
Published: August 16, 2025
Selected aspects of epidemiology of multiple sclerosis in Poland: a multicenter pilot study.
Journal: Neurologia i neurochirurgia polska
Published: July 21, 2025
Therapeutic Potential of Compounds with High Affinity to BAG2 in Inhibiting Keloid Disease.
Journal: Biologics : targets & therapy
Published: June 03, 2025
The effect of disease-modifying therapies on brain volume loss and disability accumulation in multiple sclerosis: a systematic review and network meta-analysis.
Journal: The Lancet regional health. Europe
Published: May 30, 2025
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
Journal: Journal of neurology
Published: May 23, 2025
Last Updated: 04/28/2026